Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The stomach needs time to empty and recover
The FDA-approved escalation for tirzepatide begins at 2.5mg weekly for four weeks, then increases in 2.5mg increments every four weeks as tolerated, up to a maximum of 15mg weekly
Accessed June 20, 2024.
Radunz CL, Okuyama CE, Branco-Barreiro FCA, Pereira RMS, Diniz SN
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes and weight management in the UK Dizziness may result from dehydration due to gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or reduced caloric intake Seek urgent medical attention if dizziness occurs with chest pain, severe headache, stroke symptoms, loss of consciousness, or severe abdominal pain Management includes maintaining adequate hydration, rising slowly from sitting or lying positions, monitoring blood glucose levels, and ensuring balanced nutrition Report persistent or concerning symptoms to your GP or via the MHRA Yellow Card Scheme for ongoing medication safety monitoring Table of Contents Understanding Mounjaro and Its Common Side Effects Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus
US$ 29.82
US$ 22.68
US$ 27.41
US$ 20.57
US$ 27.47
US$ 21.35
US$ 29.05
US$ 22.19
US$ 24.00
US$ 27.14
